Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Do New Genes Hold the Key to Human Cell Division?
Research & Development Do New Genes Hold the Key to Human Cell Division?

Ivan Kairatov, a notable expert in biopharma with a rich background in tech and innovation within the industry, lends his insights on a recent groundbreaking study in human cell cycle regulation. The study, led by the team at EPFL, unveils how newly evolved genes are integral to the complex process

Can Personalized Diets Revolutionize Food Sensitivity Research?
Research & Development Can Personalized Diets Revolutionize Food Sensitivity Research?

Personalized diets are emerging as a beacon of hope in the complex world of food sensitivity research, offering potential solutions to a pervasive and intricate problem. Food sensitivities, distinct from well-known allergies, are linked to immune responses involving IgA and IgG antibodies. These

Are Patient-Friendly Drug Formulations the Future of Cancer Care?
Management & Regulatory Are Patient-Friendly Drug Formulations the Future of Cancer Care?

The field of cancer treatment has witnessed significant innovations, especially in the formulation of drugs designed to ease patient administration. The European Medicines Agency's endorsement of zanubrutinib tablets, Brukinsa's newer form, highlights an essential shift toward treatments that

Are We Ignoring Genetic Diversity in NLSDM?
Research & Development Are We Ignoring Genetic Diversity in NLSDM?

Neutral Lipid Storage Disease with Myopathy (NLSDM) represents one of the intriguing frontiers of genetic and medical research. This rare disorder offers a novel perspective on how genetic mutations can shape phenotypic manifestations and lead to significant metabolic and muscular complications.

Are You Following Safe Biohazard Disposal Practices in Restrooms?
Biotech & Bioprocessing Are You Following Safe Biohazard Disposal Practices in Restrooms?

The management of biohazardous waste in restrooms is an often overlooked, yet critical component of maintaining a safe and healthy environment, particularly in public facilities and healthcare settings. Every day, cleaning professionals face the significant risk of exposure to various bodily

Can Microbiome Science Revolutionize Everyday Patient Care?
Research & Development Can Microbiome Science Revolutionize Everyday Patient Care?

In an era where personalized medicine is increasingly becoming the norm, microbiome science is emerging as a pivotal player in reshaping patient care. Understanding the intricate relationship between human health and the billions of microbes that inhabit our bodies presents a unique opportunity. By

Can Gauteng's Strained MRI Services Meet Urgent Healthcare Needs?
Tech & Innovation Can Gauteng's Strained MRI Services Meet Urgent Healthcare Needs?

Gauteng’s public healthcare system faces a monumental challenge with an astonishing diagnostic backlog, where over 3,500 patients are waiting for essential MRI scans due to equipment failures and staff shortages. Only eight MRI machines are available for the region's vast population of

Enhancing CAR-T Cells to Combat Solid Tumors with CRISPR
Research & Development Enhancing CAR-T Cells to Combat Solid Tumors with CRISPR

In recent years, the battle against cancer has seen the emergence of innovative approaches, particularly in immunotherapy. Chimeric Antigen Receptor (CAR) T cell therapy, famously effective against blood cancers, faces significant hurdles when applied to solid tumors. A critical challenge is the

How Can Custom Biosecurity Plans Protect Cattle Operations?
Biotech & Bioprocessing How Can Custom Biosecurity Plans Protect Cattle Operations?

In the evolving landscape of cattle agricultural enterprises, ensuring livestock health through tailored biosecurity strategies is a vital component of successful operations. The diversity of cattle operations leads to varying levels of risk and distinct control points, highlighting the importance

EU Panel Backs Darzalex for Early-Stage Multiple Myeloma
Management & Regulatory EU Panel Backs Darzalex for Early-Stage Multiple Myeloma

In the world of oncology, advancements in treatment options often mark pivotal moments in patient care. Ivan Kairatov, a biopharma expert with profound knowledge in tech and innovation, shares insights into the nuanced landscape of smouldering multiple myeloma (SMM) and its treatment. With his

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later